UNSPSC 51271504: Salicyl alcohol

This classification denotes an anesthetic agent with the molecular formula C7H8O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FA1N0842KB, chemically known as toluene,alpha,2-dihydroxy but generally known as salicyl alcohol, which bears US NIH Compound Identifier 5146. European Medicines Agency schedules Salicyl alcohol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15177MIG. Most nations schedule salicyl alcohol under HS 29072900 and SITC 51243.

As of Q4 2014, SALICYL ALCOHOL remains the US FDA Preferred Term for this commodity. Salicyl alcohol bears US NLM identifiers UMLS ID C0073970 and NCI Concept Code C81408. SMILES: C1=CC=C(C(=C1)CO)O.

UNSPSC 51271504 Salicyl alcohol is a Commodity code encompassing chemical and pharmaceutical ingredients supplied through state and local procurement channels, though the recent activity tracked under this code reflects broader generic pharmaceutical and over-the-counter product distribution rather than salicyl alcohol as a discrete line item. State and local governments procure these materials primarily through multistate cooperative purchasing agreements that consolidate demand across participating agencies and facilities, leveraging volume to negotiate competitive pricing with manufacturers and authorized wholesalers. The work involves manufacturer compliance with regulatory standards—current Good Manufacturing Practices, FDA requirements, and Drug Supply Chain Security Act certification—and submission of detailed product specifications including National Drug Codes, SKUs, UPCs, dosage forms, packaging configurations, and manufacturing locations through standardized data formats.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (Solicitation S1070000015802) on January 20, 2026 for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026. The contract establishes multiple awards across participating state and local government facilities in Minnesota and Oregon, with awarded vendors distributed to three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—effective July 1, 2026. Vendors must maintain contractual relationships with at least two of the three authorized wholesalers, carry comprehensive insurance including $5,000,000 commercial general liability and $2,000,000 network security and privacy liability, and accept a 3 percent administrative fee on all contract purchases. The RFP weights evaluation at 75 percent on price competitiveness, with the remainder distributed across fixed pricing, administrative compliance, EDI capability, and administrative fee agreement.